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Vapor condensates of baseline gasoline (BGVC), or gasoline-blended with methyl tertiary butyl ether (G/
MTBE), ethyl t-butyl ether (G/ETBE), t-amyl methyl ether (G/TAME), diisopropyl ether (G/DIPE), ethanol
(G/EtOH), or t-butyl alcohol (G/TBA) were evaluated for reproductive toxicity in rats at target concentra-
tions of 2000, 10,000, or 20,000 mg/m3, 6 h/day, 7 days/week. BGVC and G/MTBE were assessed over two
generations, the others for one generation. BGVC and G/MTBE F1 offspring were evaluated for neuropa-
thology and changes in regional brain glial ﬁbrillary acidic protein content. No neurotoxicity was
observed. Male kidney weight was increased consistent with light hydrocarbon nephropathy. In adult
rats, decreased body weight gain and increased liver weight were seen. Spleen weight decreased in adults
and pups exposed to G/TBA. No pathological changes to reproductive organs occurred in any study.
Decreased food consumption was seen in G/TAME lactating females. Transient decreases in G/TAME off-
spring weights were observed during lactation. Except for a minor increase in time to mating in G/TBA
which did not affect other reproductive parameters, there were no adverse reproductive ﬁndings. The
NOAEL for reproductive and offspring parameters was 20,000 mg/m3 for all vapor condensates except
for lower offspring NOAELs of 10,000 mg/m3 for G/TBA and 2000 mg/m3 for G/TAME.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction
The 1990 amendments to the Clean Air Act (CAA) mandated the
use of oxygenates in motor gasoline. In 1994, the U.S. Environmen-
tal Protection Agency (EPA) issued a ﬁnal rule under the Act which
added new health effects information and testing requirements to
the Agency’s existing registration requirements. As described in
more detail in a companion paper (Henley et al., 2014), require-
ments included inhalation exposures to evaporative emissions of
the gasoline or the gasoline-additive blend in question. The health
endpoints include assessments for standard subchronic toxicity,neurotoxicity, genotoxicity, immunotoxicity, developmental and
reproductive toxicity, and chronic toxicity/carcinogenicity. The
results of chronic toxicity testing of gasoline and gasoline
combined with MTBE have already been reported (Benson et al.,
2011) and reported elsewhere in this issue are the ﬁndings for
subchronic toxicity testing (Clark et al., 2014), genotoxicity
(Schreiner et al., 2014), neurotoxicity (O’Callaghan et al., 2014),
immunotoxicity (White et al., 2014) and developmental toxicity
testing in mice and rats (Roberts et al., 2014a,b). This paper
describes the results of reproductive toxicity tests performed sep-
arately and submitted to EPA.
Test materials evaluated in the reproductive toxicity studies
included vapor condensates prepared from an EPA described
‘‘baseline gasoline’’ (without oxygenate) (BGVC), as well as the
vapor condensates of gasoline blended with oxygenates
(11.3–21.3 wt.%)methyl tertiary butyl ether (G/MTBE), ethyl t-butyl
ether (G/ETBE), t-amyl methyl ether (G/TAME), diisopropyl ether
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condensates represent the more easily vaporized fractions of the
various gasolines and thusmore accurately reproduce human expo-
sure during vehicle fueling and other operations. Baseline gasoline
(BGVC) and G/MTBE were evaluated in two-generation studies
which included neuropathology assessments and quantitative
changes in regional brain glial ﬁbrillary acidic protein (GFAP) con-
tent, a measurement of reactive gliosis and an index of underlying
neurotoxicity, in F1 offspring. All other vapor condensates were
evaluated in one-generation reproductive toxicity studies. The goal
of the studieswas to provide information on the extent towhich the
use of oxygenates in gasoline might alter the hazard of evaporative
emissions that are encountered during refueling of vehicles, com-
pared to those from gasoline alone.2. Materials and methods
2.1. Test material preparation and characterization
Gasoline and gasoline/oxygenate vapor condensates were pre-
pared and supplied in 100 gallon gas cylinders by Chevron
Research and Technology Center (Richmond, CA). Since only 5-gal-
lon cylinders were practical for use in exposure operations, the test
material was dispensed as needed at the testing facility from the
100 gallon cylinders into 5-gallon cylinders using nitrogen pressur-
ization. The methodology for preparation and analytical character-
ization of the samples is described in a companion paper (Henley
et al., 2014). Test materials included vapor condensates prepared
from an EPA described ‘‘baseline gasoline’’ (BGVC), identiﬁed as
API Lot 99-01, and gasoline blended with methyl tertiary butyl
ether (G/MTBE), ethyl t-butyl ether (G/ETBE), t-amyl methyl ether
(G/TAME), diisopropyl ether (G/DIPE), ethanol (G/EtOH), or t-butyl
alcohol (G/TBA).2.2. Experimental design
The test materials were administered via whole-body inhala-
tion exposures to Sprague Dawley rats (26/sex/dose group) at tar-
get concentrations of 2000, 10,000 and 20,000 mg/m3 for 6 h/day,
7 days/week over two-generations for BGVC and G/MTBE (Table 1)
and for one generation for the ﬁve other gasoline/oxygenate blends
(Table 2).
The control group in each study received air only while in the
chamber. Studies were performed at Huntingdon Life Sciences
(East Millstone, NJ.) in accordance with US EPA OPPTS 870.3800
reproductive guidelines which address both one-generation and
two-generation studies (US EPA, 1998a). In the two-generation
studies of BGVC and G/MTBE, F1 pups (5/sex/group/assessment)
not selected for F1 mating were evaluated for neurotoxicity byTable 1
Experimental design: two generation studies (BGVC, G/MTBE).
Exposure levels (mg/m3)a Number of animals
Mated adults Microscopic patholo
P0 F1 P0
M F M F M F
0 (air only) 26 26 26 26 10 10
2000 26 26 26 26 – –
10,000 26 26 26 26 – –
20,000 26 26 26 26 10 10
a Exposures daily, 7 days/week for 6 h per day.
b F1 pups (5/sex/group/assessment) not selected for F1 mating were evaluated for stan
CFR 79.67) on Postpartum Day 27 or 28.standard Tier 2 neuropathology (per 40 CFR 79.66; US EPA,
1998b) and GFAP (per 40 CFR 79.67; US EPA, 1994b).
2.3. Animal selection, assignment and care
CD (Sprague–Dawley derived) [Crl: CD@ IGS BR] albino rats
(approximately 27–29 days of age) were received from Charles
River Laboratories (Kingston, NY) for each study. Females were
nulliparous and non-pregnant. Animals were acclimated for at
least 13 days after receipt and examined to conﬁrm suitability
for study. After selection for study (P0 generation) each rat was
identiﬁed with a metal ear-tag bearing its assigned animal number.
In the two-generation studies, selected F1 parental animals were
ear-tagged with a unique number at the time of selection.
Animals considered suitable for study on the basis of pretest
physical examinations and body weight data were randomly
assigned, by sex, to control or treated groups in an attempt to
equalize mean group body weights. Individual weights of animals
placed on test were within ±20% of the mean weight for each sex
for each study. Animals were approximately 40–42 days of age at
initiation of exposure. Currently acceptable practices of good ani-
mal husbandry were followed (National Academy of Sciences,
1996). Huntingdon Life Sciences, East Millstone, New Jersey is fully
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC). Certiﬁed Rodent
Diet, No. 5002; (Meal) (PMI Nutrition International, St. Louis, Mis-
souri) was available without restriction except during exposure.
Water was available without restriction, except during exposures,
via an automated watering system. Food and water were analyzed
for purity on a regular basis and there were no known contami-
nants which were expected to interfere with the results of this
study.
2.4. Housing and environmental conditions
Animals were individually housed in suspended stainless steel
cages with wire mesh fronts and ﬂoors with the following
exceptions: when mated, one male and one female were co-housed
continuously (except during exposure) until mating occurred or for
a maximum of 14 days; during lactation, dam and litter were
housed together in a solid plastic ‘‘shoebox’’ cage with ground corn
cob bedding, (Bed-O-Cobs 1=4 inch irradiated, The Andersons Inc.
Maumee, OH), changed at least weekly until weaning.
A 12 h light/dark cycle controlled via an automatic timer was
provided. Temperature and relative humidity were monitored in
accordance with testing facility SOPs and maintained within the
speciﬁed range (18–26 C, and 30–70%, respectively) to the
maximum extent possible. Air changes were maintained within a
range of 10–15/h. Excursions outside the speciﬁed range were
not considered to have affected the integrity of the study.gy adult generations Macroscopic postmortem exams – pupsb
F1 F1 F2
M F
10 10 3/sex/litter 3/sex/litter
– – 3/sex/litter 3/sex/litter
– – 3/sex/litter 3/sex/litter
10 10 3/sex/litter 3/sex/litter
dard Tier 2 Neuropathology (as per 40 CFR 79.66) and GFAP assessments (as per 40
Table 2
Experimental design – one generation studies (G/TAME, G/ETBE, G/DIPE, G/ETOH, G/TBA).
Exposure level (mg/m3)a Number of animals
Mated adults Microscopic pathology adult generations Microscopic postmortem examinations – pups
P0 P0 F1
M F M F
0 (air only) 26 26 10 10 3/sex/litter
2,000 26 26 – – 3/sex/litter
10,000 26 26 – – 3/sex/litter
20,000 26 26 10 10 3/sex/litter
a Exposures daily (7 days/week) for 6 h per day.
Table 3
Exposure schedule.
Study Phase P0 Females P0 Males
GD20 -  LD 4 F1 Females F1 Males 
F1 weaning at LD28 P0 dams and F1 pups not mating Sacrificed
5/sex/litter for 
F2 mating. 
5/sex/litter for 
F2 mating
GD20 -  LD 4
F2 weaning at LD-28 F1 dams and F2 pups
F1 sires and F2 
pups
Shaded areas indicate exposure periods (6hrs/day, 7 days/week)
Gestation days 0-19 exposure
Lactation days 5-28
Premating 70 days (10 weeks)
One Generation Second generation
Premating 70 days (10 weeks)
Gestation  GD 0-19 exposure
Lactation days 5-28
Mating 14 days
Mating   14 days
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The test material was administered as a vapor in the breathing
air of the animals as described in Clark et al. (2014). Maximumexposure levels were 50% of the lower ﬂammable limits of these
test materials.
The exposure schedules are summarized on Table 3. P0 males
and females received 70 consecutive days (10 weeks) of exposure
T.M. Gray et al. / Regulatory Toxicology and Pharmacology 70 (2014) S48–S57 S51prior to mating for 6 h/day, 7 days/week and continued to be
exposed during the 14-day mating period. Mated females were
exposed daily from Gestation day 0 (GD0) through GD19.
Females were not exposed after GD19 through lactation day 4
(LD4). Beginning on LD5, nursing P0 females were exposed daily
until weaning on LD28. P0 females with no conﬁrmed day of mat-
ing continued exposure for 25 days following completion of the
mating period. P0 females with no conﬁrmed day of mating but
with evidence of pregnancy (weight gain) were exposed until pre-
sumed GD19 and females with a conﬁrmed day of mating that did
not deliver were sacriﬁced on presumed GD25. P0 males were
exposed daily and sacriﬁced on the date proximate to the date of
the ﬁrst litter weaning or after the last day F1 pups were delivered
(approximately 16–20 weeks of exposure).
Two generation studies: Selected F1 males and females (26
mating pairs/group) started exposure at weaning on LD28 and con-
tinued treatment for 10 weeks prior to pairing to produce the F2
generation. Exposure continued through the 14 day mating period.
Mated F1 females were exposed daily from GD0 through GD19. F1
females were not exposed after GD19 through lactation day 4
(LD4). Beginning on LD5, nursing F1 females were exposed daily
until weaning of the F2 generation on LD28. F1 males were
exposed daily and sacriﬁced on the date proximate to the date of
the ﬁrst F2 litter weaning.
2.6. Exposure procedures
Details of exposure procedures and chamber operation and dia-
gram of the exposure chambers are described in Clark et al. (2014).
The ﬂow of air through the chamberwasmonitored using appropri-
ate calibrated equipment. Exposure levels were analyzed using an
infra-red spectrophotometer 4 times per chamber per day. The test
material’s major components were assayed once per chamber per
week. Particle size distribution measurements were also made
once per chamber per week using a TSI aerodynamic particle sizer.
2.7. Study performance
Viability checks were performed twice daily for mortality and
signs of severe health effects. Physical observations and body
weights were recorded twice pretest (P0 generation) and at least
weekly during the study. Food consumption was measured begin-
ning the week prior to treatment initiation (P0 generation) and at
least weekly during the study. For P0 and F1 dams, body weight
and food consumption were measured on Gestation Days [GD] 0,
7, 14, 20 and on Lactation Days [LD] 1, 4, 7, 14, 21 and 28. All
parental male animals were sacriﬁced during the lactation period
for a total of 16–20 weeks of exposure and all parental females
(P0 and F1) were sacriﬁced on their respective LD28. Females that
failed to mate were sacriﬁced 25 days after the end of the mating
period and females with conﬁrmed mating but without delivery
were sacriﬁced on presumed GD25. Non-pregnant status was con-
ﬁrmed by staining with ammonium sulﬁde for implantation sites.
Selected organs [adrenals, brain, heart, liver, lungs, kidneys, spleen,
thymus, ovaries, uterus, testes, seminal vesicles, prostate, epididy-
mides] were weighed and organ/body weight and organ/brain
weight ratios calculated. Macroscopic examinations were per-
formed on all parental rats and histological evaluations of the tis-
sue samples from the weighed organs of 10 randomly selected
rats in the control and 20,000 mg/m3 groups were performed.
Details of general histopathology procedures are found in Clark
et al. (2014). Reproductive organs from all male and bred female
rats in control and high dose groups were evaluated. Examination
of all parental females included a vaginal smear at time of necropsy
to determine stage of estrus and a count of uterine implantation
scars if present. Ovary histopathology included evaluation of theprimordial follicle population, number of growing follicles and cor-
pora lutea. Right testes and right epididymis from each animal
were removed intact, weighed (testes weighed together and sepa-
rately) and ﬁxed in modiﬁed Davidson’s solution for 48 h prior to
permanent storage in 10% neutral buffered formalin for possible
histopathology at Huntingdon Life Sciences. Sperm evaluations
included motility, testicular homogenization-resistant sperm and
cauda epididymal sperm count and sperm morphology. Sperm
evaluations were performed on specimens shipped frozen on dry
ice to Pathology Associates International, Frederick MD (PAI). Anal-
yses were performed on the left epididymis, vas deferens and left
testis.
2.8. Mating, gestation and lactation procedures for one-generation and
two-generation studies
2.8.1. Mating
Vaginal smears were taken daily for each female beginning
3 weeks prior to cohabitation for P0 and F1 rats and continuing
until there was evidence of mating or until the 14-day mating
period was ended. Following 10 weeks premating exposure, one
male and one female from the same group were mated overnight
until evidence of mating was observed or 14 days had elapsed.
The day evidence of mating was observed (a copulation plug in
the vagina and/or microscopic observation of sperm in a vaginal
smear) was deﬁned as Day 0 of gestation (GD0).
Animals were not paired during the daily exposure period. Dur-
ing mating of F1 generation, male and female littermates were
never paired together. At weaning of each F1 litter on Lactation
day (LD) 28, one pup/sex/litter was chosen at random to continue
with exposure to BGVC or G/MTBE as the F1 parental generation.
When less than 26 litters were available in a group, additional pups
from other litters within the group were selected at random to
make up 26 mating pairs/group.
2.8.2. Parturition and lactation
On GD18, exposure was ended and each female was transferred
to a plastic shoebox with bedding material and observed for evi-
dence of parturition twice daily. The day on which parturition
was observed was LD0. These females were not exposed from
GD19 [P0 and F1 dams] until exposure was resumed on LD5 to
weaning at LD28.
2.8.3. Offspring
Pups of the F1 and F2 generations were observed as soon as pos-
sible after delivery for sex, number of live and dead pups and pup
abnormalities. All pups were uniquely identiﬁed within the litter
by toe tattoo. Pups dead at delivery were identiﬁed as stillborn
or liveborn found dead based on lung ﬂoatation (air in the lungs)
evaluation. Thereafter litters were observed twice daily and litter
size was recorded daily from LD1 to LD28. On LD4, F1 litters with
more than 10 pups were randomly culled to 10 pups with sex dis-
tribution equalized if possible. Pups were examined and weighed
on LD1 (delivery day), 4 (preculled), 7, 14, 21 and 28.
2.8.4. One-generation studies (G/EtOH, G/TAME, G/ETBE, G/DIPE and G/
TBA)
Pups from one-generation studies were terminated on LD28.
Macroscopic examinations were performed on up to 3 randomly
selected pups/sex/litter on LD28 including identiﬁcation of any
structural abnormalities or pathological changes. All remaining
F1 pups were examined for external abnormalities and sacriﬁced.
Pups with abnormalities were preserved intact in 10% neutral buf-
fered formalin. Brain, spleen and thymus gland were weighed from
one randomly selected pup/sex/litter on LD28.
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At weaning one pup/sex/group was selected for mating to pro-
duce the F2 generation. F1 pups [5/sex/group/assessment] not
selected for F1 mating were evaluated for standard Tier 2 neuropa-
thology (40 CFR79.66; US EPA, 1998b) or for GFAP assessments (40
CFR79.67; US EPA, 1994b) on postpartum day 28. Methods
employed for both procedures are provided in O’Callaghan et al.
(2014). The standard Tier 2 neuropathologic evaluation was
performed at Huntingdon Life Sciences. For GFAP analyses, brains
were removed, weighed and processed, then shipped on dry ice
to the US Centers for Disease Control and Prevention, Health Effects
Laboratory Division, Morgantown, WV for analysis by Dr. James
O’Callaghan. The remaining pups were examined for external
abnormalities and sacriﬁced. Pups with abnormalities were
preserved intact in 10% neutral buffered formalin. Three pups/
sex/litter in each group (F1 and F2) were selected for macroscopic
examination and selected organs [brain, spleen, thymus] were
weighed from one pup /sex/litter.2.9. Statistical methods
For continuous data [body weights, body weight change, food
consumption, organ weight data, gestation length, pup body
weights, number of pups (live, dead, total), mean age-to-criteria
for vaginal opening and preputial separation], mean values of all
exposure groups were compared to the mean value for the concur-
rent control group at each time interval. The litter was considered
the operative unit for offspring data (e.g., pups/litter). Evaluation of
equality of groupmeans was made with standard one-way analysis
of variance (ANOVA) using the F ratio followed by Dunnett’s test
(Dunnett, 1955, 1964; Dunlap and Duffy, 1975) if needed.
For sperm and ovary data the following parameters were ana-
lyzed statistically: mean sperm count (testicular sperm count
and caudal epididymal sperm count), sperm morphology, and
motility data and numbers of primordial and growing follicles by
ovary and total. If a signiﬁcant difference occurred (p < 0.05)
between groups using the nonparametric Kruskal–Wallis test, the
Wilcoxon (Mann–Whitney U) test was used for pair-wise compar-
isons of each treated group to the vehicle control group (Games
and Howell, 1976; Kruskal and Wallis, 1952, 1953; Siegel, 1956).
Incidence data [mortality, mating indices, pregnancy rates, male
fertility indices, live birth indices, and pup viability indices (Days
0–4) and lactation indices (Days 4–28)] were analyzed using the
Chi-square test (2 x n). If Chi-square analysis was not signiﬁcant,
no additional analyses were performed (Mantel, 1963; Dunlap
et al., 1981). If Chi-square was signiﬁcant, a Fisher Exact Test with
Bonferroni correction was performed to identify differences
between the groups.
Statistical methods for the GFAP assay employed separate one-
way analysis of variance (ANOVA) for each of the brain areas from
male and female rats (JMP, SAS Institute, 1995). The signiﬁcance
level was p < 0.05 and, to ensure detection of between group treat-Table 4
Measured exposure concentrations compared to target concentrations.
Exposure levels (mg/m3) Exposure chamber concentrations – mg/
BGVC G/MTBE G/EtO
2000 Analytical 2014 ± 96 2015 ± 120 2068
10,000 Analytical 10,140 ± 369 10,240 ± 622 10,13
20,000 Analytical 20,010 ± 599 20,120 ± 776 20,30
Molecular Wt.b 73.8 73.7 65.9
a Total hydrocarbon concentrations as determined by infrared spectroscopy.
b Average molecular weight of hydrocarbons in condensate sample.ment effects, the Least Signiﬁcance-Difference test (Keppel, 1973)
was used for post hoc analyses.
2.10. Compliance
These studies were conducted in accordance with the United
States Environmental Protection Agency’s (EPA) Good Laboratory
Practice Standards (US EPA, 1994a), and complied with all appro-
priate parts of the Animal Welfare Act Regulations (USDA, 1989,
1991).The studies also met the requirements of US EPA OPPTS
870.3800 guidelines for one and two-generation reproductive tox-
icity studies (US EPA, 1998a).
3. Results
3.1. Chamber monitoring
The analytically measured exposure levels of the airborne test
material are shown in Table 4. Measured concentrations were
acceptable for this type of vapor exposure. The average molecular
weights of the hydrocarbons contained in the different condensate
samples can be used to calculate the exposure levels in approximate
part per million (ppm) concentrations. Chamber environmental
conditions averaged 24 C and 43% relative humidity. Particle sizing
results indicated that the atmospheres were essentially vapor only
(data not presented).
Table 5 provides a proﬁle of the major components in the start-
ing test materials. Analysis of the major components in the starting
test material and the test material atmospheres (20 measurements
throughout the two-generation studies and 10 measurements for
the one-generation studies) showed an acceptably close compari-
son between the starting test material and the chamber vaporized
test material (data not presented). These data demonstrate that the
test animals were exposed, as expected, to all of the major compo-
nents of the test material in their proper proportions. The data
were consistent from week-to-week during the study indicating
stability of the test material and the atmosphere generation
techniques.
3.2. Systemic Parental Effects
3.2.1. Mortality
There were no signiﬁcant effects of treatment on survival in any
study. All animals in the G/EtOH study survived to termination.
Mortality among parental animals in other studies was incidental
to mishandling or self-inﬂicted injuries (broken limbs or tooth
damage). Litter survival results are presented in Section 3.3.
3.2.2. Parental data
Parental animal data are summarized in Table 6a (Females) and
Table 6b (Males). To facilitate comparisons across test materials the
data are presented for the 20,000 mg/m3 groups only. Statistical
signiﬁcance was determined by comparison with concurrent airm3 ± standard deviationa
H G/TAME G/ETBE G/DIPE G/TBA
± 224 2060 ± 239 2040 ± 109 2034 ± 128 2015 ± 176
0 ± 320 10,500 ± 516 10,450 ± 507 10,260 ± 621 10,254 ± 355
0 ± 1042 20,500 ± 1184 20,420 ± 815 20,230 ± 775 20,382 ± 928
77.2 77.1 76.5 72.1
Table 6a
Effects on female rats (P0 and F1) from exposure to vapor condensates of baseline gasoline or gasoline/oxygenate blends at 20,000 mg/m3.
Endpoints Control range BGVC G/MTBE G/TAME G/ETBE G/DIPE G/EtOH G/TBA
P0 F1 P0 F1 P0 P0 P0 P0 P0
Females
Premating body weight gain (g) 108–144 (P0) 175–200 (F1) 125** 189 129** 154** 103 111** 126 131 110*
% of control 89.3% 94.5% 89.6% 96.0% 95.4% 88.1% 97.7% 91.0% 90.2%
Gestation day 0–20 weight gain (g) 113–129 (P0) – 120, 121 (F1) 125 122 129 121 129 125 122 129 128
% of control 101.6% 100.8% 95.3% 115.4% 104.0% 98.4% 107.9% 102.4% 103.2%
Lactation day 21–28 weight gain (g) 3 to 13 (P0) 7–15 (F1) 1 7 15 8⁄ 10 11 8 17 19**a
% of control (control-3) 100.0% 115.4% 53.3% 100.0% 110.0% (control -1) 100.0% 380.0%
Lung, discolored foci (macroscopic) 0/26–4/26 1/26 5/26 5/26 15/26* 5/26 2/23 10/26 4/26 14/26**
% of rats 0–15.4% 3.8% 19.2% 19.2% 57.7% 20.0% 8.7% 38.5% 15.4% 53.8%
Relevant organ weight changes " kidney NE " liver NE " kidney NE NE NE ; spleen
Statistical signiﬁcance based upon comparison to each study’s concurrent control.
NE = no effect.
* p < 0.05.
** p < 0.01.
Table 6b
Effects on male rats (P0 and F1) from exposure to vapor condensates of baseline gasoline or gasoline/oxygenate blends at 20,000 mg/m3.
Endpoints Control range BGVC G/MTBE G/TAME G/ETBE G/DIPE G/EtOH G/TBA
P0 F1 P0 F1 P0 P0 P0 P0 P0
Males
Premating body
weight gain (g)
225–313 (P0)
350–379 (F1)
250 364 273 321* 213 239** 284 285 287*
% of control 95.8% 96.0% 98.9% 91.7% 94.7% 85.7% 97.3% 82.2% 91.7%
Lung, discolored
foci (macroscopic)
0/26–4/26 2/26 1/26 3/26 1/26 1/16 6/26 6/26 3/26 12/26
% of rats 0–15.4% 7.7% 3.8% 11.5% 3.8% 3.8% 23.1% 23.1% 11.5% 46.2%
Relevant organ
weight changes
" kidney " kidney " kidney, liver " kidney, liver " kidney, liver " kidney, liver " kidney, liver " kidney " kidney, ; spleen
Statistical signiﬁcance based upon comparison to each study’s concurrent control.
* p < 0.05.
** p < 0.01.
Table 5
Representative hydrocarbon distribution in vapor condensate test materials.a
Hydrocarbons detected in test material (area percent)a
BGVC B/MTBE G/EtOH G/TAME G/ETBE G/DIPE G/TBA
Isobutane 3.6 2.2 2.2 1.9 2.0 2.0 3.0
n-butane 15.2 11.1 11.6 10.4 10.6 11.5 9.9
Isopentane 35.1 31.0 34.0 33.6 32.5 32.2 25.2
n-pentane 13.2 9.1 10.2 10.3 9.8 9.6 11.6
trans-2-pentene 2.5 2.0 2.1 2.3 2.1 2.1 2.1
2-methyl-2-butene 3.8 2.9 3.1 3.4 3.2 3.1 3.2
2,3-dimethylbutane 1.6 0.9 2.2 1.5 1.4 1.3 1.6
2-methylpentane 6.3 4.5 5.1 5.6 5.1 4.5 6.1
3-methylpentane 3.6 2.6 2.9 3.2 2.9 2.7 3.8
n-hexane 3.0 2.1 2.4 2.6 2.4 1.8 3.4
Methylcyclopentane 1.5 1.1 1.2 1.4 1.3 1.0 1.6
2,4-dimethylpentane 1.0 0.9 1.0 1.2 1.0 1.0 1.0
Benzene 2.1 1.5 1.6 2.0 1.8 1.8 2.0
2-methylhexane 1.1 1.0 1.1 1.2 1.1 1.1 1.3
2,3-dimethylpentane 1.1 1.0 1.1 1.3 1.1 1.1 1.3
3-methylhexane 1.3 1.1 1.2 1.5 1.3 1.3 1.5
Isooctane 1.3 1.2 1.3 1.5 1.4 1.4 1.5
Toluene 3.0 2.5 2.4 3.2 2.7 2.6 3.4
MTBE 21.3
EtOH 13.3
TAME 11.9
ETBE 16.3
DIPE 17.8
TBA 16.5
a Values for these 18 reference hydrocarbons were derived pre-study (Henley et al., 2014). A total of 131 peaks were separated and identiﬁed for the BGVC study. The
reference hydrocarbons comprised over 81% of the total mass but are normalized to 100% to ease comparison between labs.
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studies at individual dose groups.
There were no remarkable clinical observations reported in any
of the studies. Statistically signiﬁcant reduction in weight gain dur-
ing the premating period was observed in females exposed to
20,000 mg/m3 BGVC (P0) G/MTBE (P0 and F1), G/ETBE and G/
TBA. No effects on maternal body weight gains occurred during
gestation (GD0–20) and lactation (LD1–28) with two exceptions.
The average body weight gain of G/MTBE F1 20,000 mg/m3 dams
during lactation was 53% of the control value. The G/MTBE LD1–
28 F1 control value of 15 g was considered comparatively high in
relation to other lactation weight gains. The lactation weight gain
of G/TBA dams of 19 g was signiﬁcantly higher than the concurrent
control of 5 g and the highest concurrent control value range of
13 g in P0 dams. Neither of these weight gain changes during lac-
tation was considered biologically signiﬁcant.
Among males, decreased body weight changes were seen in
parental animals in G/ETBE and G/TBA studies and in the F1 gener-
ation animals exposed to G/MTBE.
Food consumption (data not shown) was comparable to concur-
rent controls for BGVC, G/MTBE (P0), G/ETBE, G/DIPE, G/EtOH and
G/TBA. G/MTBE exposed rats had decreased food consumption (5–
10%) in all F1 animals (especially males) during the ﬁrst 7 weeks of
the 10 week premating period. Food consumption of G/TAME
exposed rats was comparable to controls through premating, mat-
ing and gestation but was decreased in all female dose groups
throughout the lactation period. Decreased food consumption ran-
ged from 10% to less than 15% below controls especially during the
mid-lactation period LD7–14 and LD14–21 (p < 0.01 at 20,000 mg/
m3; p < 0.01 or 0.05 at 10,000 and 2000 mg/m3).
All test material exposure caused a statistically signiﬁcant
increase in male kidney weights in the 10,000 and 20,000 mg/m3
groups consistent with light hydrocarbon nephropathy (data not
shown). Slight increases in female kidney weights were observed
at 20,000 mg/m3 in BGVC P0 and G/TAME studies. Other organ
weight changes included increased liver weights in G/MTBE
20,000 mg/m3 P0 males and females and in F1 males, and in males
exposed to G/TAME, G/ETBE, and G/DIPE. Statistically signiﬁcantly
decreased spleen weights were seen in G/TBA male rats at the mid
and high dose and in females at all dose levels. Increases in epidid-Table 7
Effects on offspring (F1 and F2) from exposure of parents to vapor condensate of gasoline
Endpoints Control range BGVC G/MTB
F1 F2 F1
Litter size (Pups delivered) 12.1–14.5 13.7 13.2 14
Pup weights (g) sexes combined
LD 1 6.8–7.4 7 7 7.2
LD 4 9.7–11.4 10.1 10.2 10.1
LD 7 13.5–14.7 13.8 13.9 13.8
LD 14 23.7–26.0 23.3 24.7 24.2
LD 21 38.7–42.5 38.8 41.2 40.6
LD 28 69.5–78.8 66.1 75.4 74.8
Pup survival sexes combined
LD 0–4 93.1–99.6% 93.8% 95.4% 98.9%
LD 5–21 98.7–100% 100.0% 99.6% 99.6%
Other endpoints
Spleen weight (g) 0.263–0.327 0.232* 0.306 0.312
GFAP assayb Negative NE Negativ
Vaginal opening (day) 35.3–37.5 35 NE 36.3
Preputial separation (day) 46.2–46.4 48 NE 46.8
Statistical signiﬁcance based upon comparison to each study’s concurrent control.
NE = not evaluated.
* p < 0.05.
** p < 0.01.
a Signiﬁcantly better survival than concurrent control (93.1%).
b GFAP details in Tables 9 and 10.ymal absolute weights at 10,000 and 20,000 mg/m3 and seminal
vesicles/coagulating gland absolute weight and relative to body
and brain weights at 20,000 mg/m3 were present in G/DIPE males
and increased prostate weight, absolute and relative to body
weight at 20,000 mg/m3 was seen in G/EtOH animals. None of
these organ weight increases were accompanied by adverse histo-
pathology ﬁndings. The minor differences to male organ weights in
the G/EtOH and G/DIPE studies did not occur in a dose-responsive
manner and were interpreted as unlikely to be due to exposure or
of toxicological (adverse) relevance.
In the 20,000 mg/m3 G/ETBE group statistically signiﬁcant
increases in epididymis, seminal vesicle and ovary weights relative
to body weights (10%, 12%, and 13%, respectively) were considered
spurious. The absolute organ weights were comparable to controls
and the relative weights did not correlate with body weights as
conﬁrmed by supplementary covariance analysis.
Discolored (tan) foci were observed macroscopically in greater
incidence in the lungs of adult animals, most signiﬁcantly in G/
MTBE F1 females, G/TBA both sexes and G/DIPE females. These
observations were not consistent across generations exposed to
G/MTBE and were not accompanied by changes in lung weight or
histopathology.
No remarkable histopathologic changes were reported in any
study with the exception of minimal increases in aggregates of
intraalveolar macrophages in G/MTBE exposed rats, most apparent
in P0 20,000 mg/m3 males, P0 2000 mg/m3 females and F1 females
at all doses. Light hydrocarbon nephropathy was strongly indicated
in all studies by the presence of hyaline droplets in kidneys of
20,000 mg/m3 male rats (Alden, 1986). No treatment related mac-
roscopic or microscopic changes were seen in male or female
reproductive organs.
3.3. Offspring observations
Offspring observations are summarized in Table 7. There were
no effects attributable to test material exposure on litter size
(pups/litter, pups born dead/litter), number of implantation sites/
litter, pup birth weight, offspring survival, or sex ratio. Postnatal
growth of pups was transiently reduced by exposure to G/TAME
or G/TBA. Statistically signiﬁcant decreases in G/TAME pup weightor gasoline/oxygenate blends at 20,000 mg/m3.
E G/TAME G/ETBE G/DIPE G/EtOH G/TBA
F2 F1 F1 F1 F1 F1
13 14.3 13.7 13.1 14.1 14.1
6.9 6.9 7 7.3 7 7
10.1 9.6 9.9 10.5* 10.1 9.9
14 13.5 13.5 14.3 13.9 13.1
24.3 23.7** 23.5 24.3 24.1 22.7*
38.5 38.5* 38.9 41.2 39.9 37.9
72.1 73.6 71.9 76.9 75.4 71.9
97.1% 96.6% 97.4% 98.6%**a 98.3% 96.1%*
99.6% 99.5% 100.0% 95.5% 99.2% 99.5%
0.311 0.290 0.298 0.299 0.321 0.278**
e NE NE NE NE NE NE
NE NE NE NE NE NE
NE NE NE NE NE NE
Table 8
Mean GFAP levels on speciﬁc regions of rat brains of F1 generation offspring following
whole body inhalation exposure of maternal rats to gasoline (BGVC) vapor
condensate.
Brain area Control 2000 mg/m3 10,000 mg/m3 20,0000 mg/m3
Males (N = 5)
Striatum 0.33 ± 0.01a 0.38 ± 0.02 0.40 ± 0.04 0.33 ± 0.05
Hippocampus 2.01 ± 0.14 2.36 ± 0.22 2.48 ± 0.20 1.75 ± 0.20
Cortex 0.61 ± 0.05 0.72 ± 0.08 0.76 ± 0.07 0.54 ± 0.07
Olfactory Bulb 1.34 ± 0.08 1.19 ± 0.07 1.28 ± 0.08 1.13 ± 0.09
Thalamus 0.86 ± 0.07 0.88 ± 0.07 0.94 ± 0.07 0.65 ± 0.05b
Hypothalamus 1.81 ± 0.18 1.99 ± 0.20 1.73 ± 0.14 1.36 ± 0.16
Cerebellum 3.04 ± 0.07 3.34 ± 0.26 3.13 ± 0.18 2.47 ± 0.27
Rest of Brain 2.56 ± 0.25 3.00 ± 0.22 3.07 ± 0.27 2.41 ± 0.39
Females (N = 5)
Striatum 0.34 ± 0.04 0.42 ± 0.02 0.37 ± 0.04 0.35 ± 0.03
Hippocampus 2.04 ± 0.09 2.18 ± 0.09 2.26 ± 0.14 2.06 ± 0.09
Cortex 0.60 ± 0.02 0.67 ± 0.04 0.69 ± 0.04 0.63 ± 0.07
Olfactory Bulb 1.29 ± 0.11 1.37 ± 0.11 1.22 ± 0.09 1.12 ± 0.07
Thalamus 0.77 ± 0.03 0.86 ± 0.06 0.93 ± 0.06 0.73 ± 0.07
Hypothalamus 1.89 ± 0.12 1.68 ± 0.09 1.75 ± 0.18 1.68 ± 0.20
Cerebellum 2.84 ± 0.18 3.42 ± 0.30 2.94 ± 0.23 2.44 ± 0.27
Rest of Brain 2.96 ± 0.52 2.94 ± 0.20 3.32 ± 0.42 2.64 ± 0.22
a Each value represents the mean ± SEM for the concentration of GFAP (lg/mg
total protein).
b Statistically different from control (p < 0.05).
Table 9
Mean GFAP levels on speciﬁc regions of rat brains of F1 generation offspring following
whole body inhalation exposure of maternal rats to gasoline MTBE (G/MTBE) Vapor
Condensate.
Brain area Control 2000 mg/m3 10,000 mg/m3 20,0000 mg/m3
Males (N = 5)
Striatum 0.35 ± 0.02a 0.41 ± 0.02 0.39 ± 0.03 0.42 ± 0.05
Hippocampus 2.31 ± 0.15 2.06 ± 0.13 2.28 ± 0.20 2.28 ± 0.24
Cortex 0.78 ± 0.07 0.75 ± 0.05 0.69 ± 0.03 0.78 ± 0.04
Olfactory Bulb 1.43 ± 0.11 1.36 ± 0.12 1.26 ± 0.09 1.36 ± 0.20
Thalamus 0.79 ± 0.08 0.83 ± 0.03 0.89 ± 0.10 0.91 ± 0.11
Hypothalamus 1.81 ± 0.09 1.87 ± 0.28 1.56 ± 0.13 2.11 ± 0.27
Cerebellum 2.72 ± 0.07 2.66 ± 0.14 2.70 ± 0.16 2.95 ± 0.39
Rest of Brain 2.86 ± 0.24 2.60 ± 0.10 2.75 ± 0.24 3.17 ± 0.47
Females (N = 5)
Striatum 0.36 ± 0.05 0.38 ± 0.06 0.43 ± 0.04 0.39 ± 0.03
Hippocampus 2.36 ± 0.24 2.37 ± 0.08 2.16 ± 0.30 2.26 ± 0.12
Cortex 0.68 ± 0.06 0.77 ± 0.06 0.78 ± 0.04 0.79 ± 0.10
Olfactory Bulb 1.22 ± 0.09 1.34 ± 0.08 1.51 ± 0.10 1.27 ± 0.03
Thalamus 0.81 ± 0.07 0.91 ± 0.05 0.89 ± 0.05 0.82 ± 0.05
Hypothalamus 1.61 ± 0.14 2.10 ± 0.21 1.90 ± 0.18 1.69 ± 0.17
Cerebellum 2.78 ± 0.29 2.72 ± 0.10 2.91 ± 0.15 2.81 ± 0.18
Rest of Brain 3.08 ± 0.27 3.08 ± 0.16 3.45 ± 0.36 2.90 ± 0.21
No values were statistically different from control (p < 0.05).
a Each value represents the mean ± SEM for the concentration of GFAP (lg/mg
Total protein).
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ued to be statistically smaller for male pups and combined sexes in
the 20,000 mg/m3 group on LD21. At 2000 mg/m3, pup weight was
reduced on LD21 for male and combined sexes as was weight gain
for intervals LD4–21 and 14–21. However, weights of mid-dose
(10,000 mg/m3) G/TAME exposed males and all F1 females were
not statistically different from controls at LD21 and there were no
statistically signiﬁcant differences from controls for any exposure
group on postnatal day 28. In offspring of females exposed to G/
TBA there was a slight but statistically signiﬁcant decrease in pup
weight gains early in lactation up to LD14 but weights were compa-
rable to controls by LD21 and postnatal day 28.
No adverse effects were seen on offspring organ weights with
the exception of reduced spleen weights in both sexes from the
G/TBA exposed group. Spleen weights were also reduced in theG/TBA parental rats. Lower spleen weights were seen in F1 off-
spring of BGVC exposed rats; however the effect was not expressed
to the F2 offspring and was unlikely to be a toxicologically signif-
icant adverse ﬁnding. Expressions of sexual maturation (vaginal
opening and preputial gland separation) were not altered by expo-
sure to BGVC or G/MTBE. Additionally there were no decrements in
reproductive performance when the F1 animals (1/sex/litter) were
bred to produce the second generation.
Neuropathology and GFAP assessments were performed on
randomly selected F1 pups from BGVC and G/MTBE exposed rats.
No adverse neuropathology was observed and there were no differ-
ences between control and BGVC or G/MTBE F1 offspring in brain
length or width. GFAP results are presented in Tables 8 and 9.
Exposure to either test material did not cause changes in GFAP lev-
els in any brain region examined with the exception of a single
decrease in the BGVC F1 male thalamus at 20,000 mg/m3 that
was not considered biologically signiﬁcant by the investigator.
Overall, GFAP results indicated that none of these substances
induced gliosis in the brain regions examined.
3.4. Reproductive parameters
Reproductive parameters are summarized in Table 10. There
were no differences in male and female fertility or reproductive
performance with exposure to any test material. Estrus cyclicity
and semen parameters were comparable between exposed and
concurrent control groups. A slight non-signiﬁcant lengthening in
the number of days of pairing until mating occurred in animals
exposed to 20,000 mg/m3 G/TBA, due to 7 of 23 pairs that failed
to mate during the ﬁrst or second estrus opportunity. However,
there were no differences in acyclics, persistent estrus or irregular
cycles and the lengthening did not translate to observed effects on
endpoints of reproductive performance. There was a slight increase
in abnormal sperm (2%) in 20,000 mg/m3 G/MTBE P0 males that
was not seen in F1 males. A statistically signiﬁcant increase in
epididymal sperm count of G/MTBE P0 males was not considered
biologically signiﬁcant due to a low concurrent control value and
the absence of a similar response in F1 males.4. Discussion
Table 11 presents No Observed Adverse Effects Levels (NOAEL)
and rationales for parental, reproductive and offspring results. Kid-
ney weight changes in male rats consistent with light hydrocarbon
nephropathy are excluded from the parental NOAEL determina-
tions because this ﬁnding has been generally accepted scientiﬁ-
cally as not relevant to the assessment of human health risk
assessment (US EPA, 1991). No neuropathology or neurotoxicity
expressed as GFAP changes were observed in F1 offspring in BGVC
or G/MTBE studies.
4.1. Parental assessments
The BGVC parental NOAEL was based on decreased body weight
gains during the premating period in P0 females and F1 males and
increased P0 female kidney weight which had no histopathologic
correlate. The G/ETOH parental NOAEL was also due to decreased
body weight gain in 20,000 mg/m3 animals, during the initial
3 weeks of the premating period. The G/MTBE parental NOAEL
could not be determined due to minimal increased incidence of
intraalveolar macrophages most apparent in P0 high dose males,
P0 low dose females and all F1 animals. Decreased food consump-
tion was seen in all F1 animals during the 7 week premating period
when inhalation exposure to G/MTBE was initiated beginning at
weaning on postnatal day 28.
Table 10
Effects on reproductive parameters on parental animals (P0 and F1) from exposure to vapor condensates of gasoline or gasoline/oxygenate blends at 20,000 mg/m3.
Endpoint Control range BGVC G/MTBE G/TAME G/ETBE G/DIPE G/EtOH G/TBA
P0 F1 P0 F1 P0 P0 P0 P0 P0
Male Fertility 20/25–25/26 25/26 24/25 26/26 24/25 24/26 23/25 23/26 25/26 22/25
80–96.2% 96.2% 96.0% 100.0% 96.0% 92.3% 92.0% 88.5% 96.2% 88.0%
Female Fertility 21/24–25/25 25/25 25/25 26/26 24/24 23/25 23/25 23/23 25/26 22/22
87.5–100% 100.0% 100.0% 100.0% 100.0% 92.0% 92.0% 100.0% 96.2% 100.0%
Number of Litters 20–25 25 25 26 24 23 23 23 25 22
Days to Mating 2.4–3.4 2.6 2.7 3.2 3.3 2.9 2.8 3.1 2.8 4
Estrus Cycle Length (days) 4.2–5.2, 5.7 4.5 4.1 5.3 4.3 5 4.2 4.3 4.3 4.1
Semen parameters
Sperm Count, testis (106/g) 81.2–124.1 115.4 100.6 108.5 102.2 93.5 106.5 103.9 104.5 108.3
Motility (%) 89–96% 94% 95% 91% 91% 88% 94% 93% 95% 90%
Morphology (% abnormal) 0.6–1.7%a 1.20% 0.50% 2.0%* 0.60% 1.90% 0.60% 0.4%*b 0.70% 0.50%
Epididymal sperm Count (x 106/g) 753.6–956.7 955.3 933.5 891.2*c 933.1 855.7 1053 927.9 832.4 793.9
Statistical signiﬁcance based upon comparison to each study’s concurrent control.
⁄⁄p < 0.01.
* p < 0.05.
a Did not include control value of 7.4% from the G/DIPE study, which was inﬂuenced strongly by two males with abnormally high percentages (90.5% and 84%) of
amorphous sperm heads.
b Signiﬁcantly fewer abnormal sperm than concurrent control (7.4% abnormal).
c Signiﬁcantly higher sperm count than low concurrent control value of 753.6 [PAI historical control average = 869.9].
Table 11
No observed adverse effect levelsa.
Study BGVC G/MTBE G/TAME G/ETBE G/DIPE G/EtOH G/TBA
Parental 10,000 <2000 <2000 2000 2000 10,000 <2000
Decreased body weight gain P0
females, F1 males. Increased P0
female kidney weight
Increased intra-alveolar
macrophages in some P0 and all F1
rats. Decreased food consumption
in F1 rats
Decreased food
consumption in
all lactating
females
Increased
liver
weights
Increased
liver
weights
Decreased
body
weight gain
Decreased
spleen weights
at all dose levels
Reproductive 20,000 20,000 20,000 20,000 20,000 20,000 20,000
No adverse effects No adverse effects No adverse effects No
adverse
effects
No adverse
effects
No adverse
effects
No adverse
effects
Offspring 20,000 20,000 2000 20,000 20,000 20,000 10,000
No adverse effects No adverse effects Decreased pup
body weight
No
adverse
effects
No adverse
effects
No adverse
effects
Decreased
spleen weights
a NOAEL determination excluded male rat kidney hydrocarbon nephropathy as not relevant to human risk assessment.
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increased liver weights (absolute and relative to body weight) in
the mid and high dose groups. The G/TBA parental NOAEL could
not be determined based on statistically signiﬁcant decreased
spleen weights at all dose levels in females and at the mid and high
dose levels in males. Although similar differences were not seen in
the 13 week inhalation dose study (Clark et al., 2014) that study
involved smaller group sizes and only 65 exposures on a 5 day/
week regime whereas this study involved at least 112 consecutive
daily exposures. G/TAME parental males had increased liver
weights (absolute and relative to body weight) at 10,000 and
20,000 mg/m3 with no histologic correlates. Increased kidney
weights were seen in males at all doses reﬂective of light hydrocar-
bon nephropathy and 20,000 mg/m3 females with no microscopic
correlate. However a parental NOAEL could not be determined
due to decreased food consumption in lactating females at all doses
whichwhile not reﬂected in decreasedmaternal bodyweights, may
have contributed to decreased pup weights during lactation.4.2. Reproductive and offspring assessments
The NOAEL was the highest exposure tested for BGVC, G/MTBE,
G/ETBE, G/DIPE, G/TBA and G/ETOH as no differences from controls
were seen for fertility, days to mating, estrus cycle length, sperm
counts or morphology or developmental parameters in pups.The offspring NOAEL for G/TBA was based on decreased spleen
weight in pups from 20,000 mg/m3 exposed dams. Decreased
spleen weight was also seen in parental animals.
The G/TAME reproductive NOAEL was 20,000 mg/m3. The off-
spring NOAEL of 2000 mg/m3 was based on transient statistically
signiﬁcant reductions in pup weight gains seen over LD7–14 at
mid and high dose levels and continued in male pups and com-
bined sexes in the 20,000 mg/m3 group at LD21. However all
groups were comparable to controls by weaning at postnatal day
28. At the lowest exposure level (2000 mg/m3) although pup
weights were statistically signiﬁcantly lower at LD21 for males
and combined sex pups resulting in lower weight gains in postna-
tal intervals 5–21 and 14–21, weights recovered by postnatal day
28. Reduced pup weights during lactation was previously reported
in a two generation study with inhalation exposure of TAME alone
at concentrations of 1040, 2250 and 12,500 mg/m3 (0, 250, 1500,
3000 ppm; Tyl et al., 2003).
Developmental toxicity studies were performed in pregnant
rats using the same gasoline blended test materials at exposure
concentrations of 2000, 10,000, 20,000 mg/m3 over GD5–20.
Developmental NOAELs were 20,000 mg/m3 for BGVC, G/MTBE,
G/ETBE, G/EtOH and G/DIPE. For G/TAME and G/TBA, developmen-
tal NOAELs were 10,000 mg/m3 due to decreased fetal body weight
and increased incidence of stunted fetuses at 20,000 mg/m3 in the
G/TAME study, and increased skeletal variations, possibly related
to maternal stress (decreased body weight gain and food consump-
T.M. Gray et al. / Regulatory Toxicology and Pharmacology 70 (2014) S48–S57 S57tion) at 20,000 mg/m3 in the G/TBA study (Roberts et al., 2014b).
Developmental studies at the same doses performed with BGVC
and G/MTBE only in pregnant mice in which exposure lasted from
GD5–17 resulted in developmental NOAEL values of 2000 and
20,000 mg/m3, respectively (Roberts et al., 2014a). The NOAEL for
development in the BGVC study was conservatively based upon a
decrease in fetal weight, non-dose-responsive, that was unaccom-
panied by other indicators of delayed or reduced prenatal growth.
As with the reproduction and developmental studies in rats, there
were no ﬁndings of malformations. These studies support the ﬁnd-
ings of the reproductive studies in illustrating the absence or min-
imal effect of exposure to gasoline vapor or vapors of gasoline/
oxygenate blends on developmental parameters.
The fuel condensates were not selective toxicants to reproduc-
tion. The decreased body weights in offspring of G/TAME exposed
females correlated with the decreased food consumption of the
dams throughout lactation. The decreased spleen weights in paren-
tal animals exposed to G/TBA were also seen in offspring.
5. Conclusions
Reproductive and Offspring NOAEL values of 10,000–
20,000 mg/m3 were similar among all gasoline and gasoline/oxy-
genate blend vapor condensates tested with the exception of G/
TAME where transient decreased offspring weights resulted in a
NOAEL = 2000 mg/m3, still a very high exposure level. Exposures
of rats to concentrations of up to 50% of the lower ﬂammable limits
of evaporative emissions from these condensates indicate minimal
impact on reproductive parameters at concentrations well in
excess of potential human exposure at refueling, which typically
measure less than 1.0 mg/m3 but excursions could reach 7.0 mg/
m3 (Clayton, 1993; NATLSCO, 1995). Further, inclusion of oxygen-
ates with gasoline does not appear to alter the minimal effects of
exposure to gasoline evaporative emissions alone.References
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